Skip to content

Serotonin: all studies

Page 304 of 400: studies 3,031 to 3,040 of 3,999, newest first. Back to the serotonin overview

Research

A critical analysis of lysergic acid diethylamide in the present light!

International Journal of Advanced Psychiatric Nursing 2020 M. Baskaran, Saravanan Mani, T. Maheswari et al.

Lysergic acid diethylamide (LSD) is a semisynthetic compound with solid psychoactive properties. Chemically related to serotonin LSD was initially hypothesized to produce a psychosis-like state.1 Afterward, LSD was accounted for to have benefits in the treatment of addictions. However, far reaching unpredictable use and reports of unfriendly impacts brought about the arrangement of LSD as an...

MDMA and the Brain: A Short Review on the Role of Neurotransmitters in Neurotoxicity.

Basic and clinical neuroscience 2020 Nor Suliana Mustafa, Nor Hidayah Abu Bakar, Nasir Mohamad et al.

N-Methyl-3, 4-methylenedioxyamphetamine (MDMA), or ecstasy is a recreational drug of abuse. It is a synthetic substance that affects the body's systems, which its mechanism of action and treatment should be more investigated. MDMA provides an immediate enjoyable feeling by stimulating the release of neurotransmitters, such as dopamine and serotonin in the brain. Unfortunately, abnormal...

Classic psychedelics as therapeutics for psychiatric disorders

2020 Charles D. Nichols, P. Hendricks

Abstract Recently, there has been a resurgence of interest in the study of classic serotonergic hallucinogens, now widely referred to as classic psychedelics. These studies include fundamental molecular and cellular neuroscience and pharmacology, neuroimaging, and psychological experiments. In the early days of classic psychedelic research during the 1950s through the 1970s, classic...

Safety pharmacology and pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA)

edoc (University of Basel) 2020 Patrick Vizeli

Psychoactive substances such as the ring substituted phenylethylamine 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) are widely used in recreational settings. Additionally, recent research highlights substance-assisted psychotherapy as potential new effective treatment for various psychiatric disorders, e.g. post-traumatic stress disorder (PTSD). MDMA releases and inhibits the uptake of...

Steroids, Dissociatives, Club Drugs, Inhalants, and Hallucinogens

Absolute Addiction Psychiatry Review 2020 Mashal Khan, Anil A. Thomas 3 citations

Anabolic-androgenic steroids, inhalants, hallucinogens, dissociative anesthetics and “club drugs” are a heterogeneous group of substances that have considerable potential for misuse and associated morbidity and/or mortality. Steroid use often goes undetected, even by addiction psychiatrists, though significant medical and psychiatric consequences often arise from chronic use. Inhalants, which...

Genetische und biochemische Grundlage der Indolalkaloidbildung in Basidiomyceten und biotechnologische Produktion des Psilocybins

Common Library Network (Der Gemeinsame Bibliotheksverbund) 2020 Janis Fricke

In der gegenwärtigen Arbeit wurden die Strukturvielfalt und die genetischen und enzymatischen Grundlagen der Indolalkaloidbiosynthese in Basidiomyceten in Psilocybe spp. untersucht. Durch in silico-Analysen und heterologe Expression ist es gelungen, die Biosynthese des Psilocybins aufzuklären, die verantwortlichen Gene zu identifizieren und die resultierenden Enzyme biochemisch und...

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers

Psychopharmacology December 18, 2019 Neiloufar Family, Émeline L. Maillet, Luke T. J. Williams et al. 142 citations

Abstract Abstract Research has shown that psychedelics, such as lysergic acid diethylamide (LSD), have profound anti-inflammatory properties mediated by 5-HT 2A receptor signaling, supporting their evaluation as a therapeutic for neuroinflammation associated with neurodegenerative disease. Objective This study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of orally...

An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression

Current Psychopharmacology December 13, 2019 Rashmi S. Pal, Nikita Saraswat, Pranay Wal et al.

Background: Depression is the neuropsychiatric disorder that can lead to the disruption of brain nerves by elevating different mechanisms and neurotransmitters such as serotonin, noradrenaline, dopamine. It can have a series of episodic events that can cross one episodic depression to another and manifest various symptoms such as agitation, melancholia, deep sadness, psychomotor retardation,...

Ayahuasca no tratamento da farmacodependência à cocaína: possíveis intervenções terapêuticas?

December 13, 2019 Vítor Bruno 1 citation

\n Alucinógenos (ALU) são substâncias psicoativas que não induzem o indivíduo à dependência, possuem perfil de segurança de uso mais alto quando comparado a outras drogas e baixa capacidade de causar tolerância ao uso. Estudos recentes propõem o uso de ALU como tratamento a algumas doenças e transtornos relacionados ao sistema nervoso central, como a depressão, ansiedade e dependência. Dentre...

Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe.

International Journal of Environmental Research and Public Health December 12, 2019 Patricia P Wadowski, Georgiana-Aura Giurgea, Oliver Schlager et al.

Objective: N-(2-methoxy) benzyl-phenethylamine (NBOMe) derivatives have a high affinity to the serotonin receptor 2A and emerged as new psychedelic agents. We report the case of a 30-year-old man admitted to the hospital because of acute ischemia of the left arm with clinical symptoms of pallor, pulselessness, paresthesia, and a motoric deficit. The patient had a history of schizophrenia and...

DOI: 10.3390/ijerph16245071 (opens in new tab) Full text (opens in new tab) Limb ischemia Phenylethylamine derivates Upper limb pain Vasospasm